Xilio Therapeutics, Inc. (XLO)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
9. 02
+0.12
+1.3483%
$
59.51M Market Cap
- P/E Ratio
- Div Yield
10,368 Volume
-1.47 Eps
$ 8.9
Previous Close Want to track XLO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xilio Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| ADD Andrew D. Dickinson GILEAD SCIENCES Inc. | 650,389 | $8.73M | $6M | -$2.73M | -31.26% |
| SRB Steve R. Bailey Frazier Life Sciences Management LP | 422,505 | $3.55M | $3.8M | $249,277.95 | 7.02% |
2026 © Marketlog. All Rights Reserved.
